Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0065 | 0.2452 | 0.2425 |
Trypanosoma brucei | hexokinase | 0.0082 | 0.3462 | 0.3439 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0878 | 0.0846 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.004 | 0.0878 | 0.0846 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.004 | 0.0878 | 0.0846 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0066 | 0.2482 | 0.2455 |
Onchocerca volvulus | 0.0082 | 0.3462 | 1 | |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0188 | 1 | 1 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0065 | 0.2452 | 0.2425 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0065 | 0.2452 | 1 |
Brugia malayi | Hexokinase family protein | 0.0082 | 0.3462 | 0.3462 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0051 | 0.1587 | 0.1587 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0065 | 0.2452 | 1 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0065 | 0.2452 | 0.1725 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0878 | 0.0846 |
Schistosoma mansoni | DNA polymerase eta | 0.0066 | 0.2482 | 0.2007 |
Echinococcus multilocularis | geminin | 0.0174 | 0.9115 | 0.903 |
Onchocerca volvulus | 0.0082 | 0.3462 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.2482 | 0.2482 |
Plasmodium vivax | hexokinase, putative | 0.0082 | 0.3462 | 0.3439 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0065 | 0.2452 | 0.5 |
Plasmodium falciparum | thioredoxin reductase | 0.0065 | 0.2452 | 0.2425 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.004 | 0.0878 | 0.0878 |
Brugia malayi | Hexokinase family protein | 0.0051 | 0.1594 | 0.1594 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0065 | 0.2452 | 1 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0065 | 0.2452 | 0.5 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0065 | 0.2452 | 0.2425 |
Trypanosoma brucei | hexokinase | 0.0082 | 0.3462 | 0.3439 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0065 | 0.2452 | 0.2425 |
Schistosoma mansoni | hexokinase | 0.0082 | 0.3462 | 0.305 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.1868 | 0.1868 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0065 | 0.2452 | 0.2425 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.004 | 0.0878 | 0.0846 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.004 | 0.0878 | 0.0846 |
Brugia malayi | hexokinase | 0.0082 | 0.3462 | 0.3462 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.004 | 0.0878 | 0.0846 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0065 | 0.2452 | 1 |
Echinococcus granulosus | hexokinase | 0.0082 | 0.3462 | 0.2833 |
Echinococcus granulosus | hexokinase type 2 | 0.0082 | 0.3462 | 0.2833 |
Echinococcus multilocularis | hexokinase | 0.0082 | 0.3462 | 0.2833 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0065 | 0.2452 | 0.2425 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0066 | 0.2482 | 0.2455 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0878 | 0.0846 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0065 | 0.2452 | 0.2425 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0065 | 0.2452 | 0.2425 |
Brugia malayi | hypothetical protein | 0.0026 | 0.0035 | 0.0035 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0043 | 0.0043 |
Trypanosoma cruzi | hexokinase, putative | 0.0082 | 0.3462 | 0.3439 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.004 | 0.0878 | 0.0878 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0065 | 0.2452 | 0.1725 |
Plasmodium falciparum | hexokinase | 0.0082 | 0.3462 | 0.3439 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0065 | 0.2452 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.004 | 0.0878 | 0.0846 |
Echinococcus granulosus | hexokinase | 0.0082 | 0.3462 | 0.2833 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0043 | 0.0043 |
Leishmania major | hexokinase, putative | 0.0082 | 0.3462 | 0.3439 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0065 | 0.2452 | 0.2425 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0878 | 0.0846 |
Echinococcus multilocularis | hexokinase type 2 | 0.0082 | 0.3462 | 0.2833 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0878 | 0.0846 |
Toxoplasma gondii | hexokinase | 0.0082 | 0.3462 | 0.3439 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0051 | 0.1587 | 0.1587 |
Brugia malayi | hexokinase type II | 0.0026 | 0.0043 | 0.0043 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0188 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0594 | 0.0594 |
Trypanosoma brucei | unspecified product | 0.0027 | 0.0124 | 0.0089 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0188 | 1 | 1 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0065 | 0.2452 | 0.2425 |
Loa Loa (eye worm) | glutathione reductase | 0.0188 | 1 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0065 | 0.2452 | 0.2425 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0035 | 0.0035 |
Entamoeba histolytica | hexokinase 2 | 0.0082 | 0.3462 | 1 |
Leishmania major | trypanothione reductase | 0.0188 | 1 | 1 |
Echinococcus granulosus | geminin | 0.0174 | 0.9115 | 0.903 |
Leishmania major | DNA polymerase kappa, putative | 0.004 | 0.0878 | 0.0846 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0065 | 0.2452 | 0.2425 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0065 | 0.2452 | 0.2425 |
Loa Loa (eye worm) | hexokinase type II | 0.0082 | 0.3462 | 0.3462 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0065 | 0.2452 | 0.2425 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0065 | 0.2452 | 0.2425 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0065 | 0.2452 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0051 | 0.1587 | 0.1587 |
Echinococcus multilocularis | hexokinase | 0.0082 | 0.3462 | 0.2833 |
Echinococcus multilocularis | hexokinase | 0.0082 | 0.3462 | 0.2833 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0027 | 0.0124 | 0.0089 |
Plasmodium falciparum | glutathione reductase | 0.0188 | 1 | 1 |
Entamoeba histolytica | hexokinase 1 | 0.0082 | 0.3462 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0174 | 0.9115 | 0.9059 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.004 | 0.0878 | 0.0302 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0065 | 0.2452 | 0.2425 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0188 | 1 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0065 | 0.2452 | 0.2425 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.004 | 0.0878 | 0.0302 |
Treponema pallidum | hexokinase (hxk) | 0.0082 | 0.3462 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0878 | 0.0846 |
Loa Loa (eye worm) | hexokinase | 0.0082 | 0.3462 | 0.3462 |
Echinococcus granulosus | dna polymerase eta | 0.0066 | 0.2482 | 0.1758 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0878 | 0.0846 |
Trypanosoma brucei | unspecified product | 0.0027 | 0.0124 | 0.0089 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0048 | 0.1389 | 0.1389 |
Leishmania major | DNA polymerase eta, putative | 0.0038 | 0.0806 | 0.0774 |
Brugia malayi | Thioredoxin reductase | 0.0188 | 1 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0065 | 0.2452 | 0.2425 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0878 | 0.0846 |
Trypanosoma brucei | unspecified product | 0.004 | 0.0878 | 0.0846 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0065 | 0.2452 | 0.1725 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0065 | 0.2452 | 0.1725 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0878 | 0.0846 |
Plasmodium falciparum | thioredoxin reductase | 0.0188 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0065 | 0.2452 | 0.5 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0065 | 0.2452 | 0.2425 |
Trypanosoma cruzi | hexokinase, putative | 0.0082 | 0.3462 | 0.3439 |
Leishmania major | DNA polymerase eta, putative | 0.0066 | 0.2482 | 0.2455 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.004 | 0.0878 | 0.0846 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0066 | 0.2482 | 0.2482 |
Trypanosoma brucei | trypanothione reductase | 0.0188 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0065 | 0.2452 | 0.2425 |
Loa Loa (eye worm) | hexokinase | 0.0051 | 0.1594 | 0.1594 |
Echinococcus granulosus | hexokinase | 0.0082 | 0.3462 | 0.2833 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0065 | 0.2452 | 0.2425 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0065 | 0.2452 | 0.2425 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0065 | 0.2452 | 0.2425 |
Loa Loa (eye worm) | hexokinase | 0.0082 | 0.3462 | 0.3462 |
Echinococcus multilocularis | dna polymerase eta | 0.0066 | 0.2482 | 0.1758 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0065 | 0.2452 | 1 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.004 | 0.0878 | 0.0846 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0027 | 0.0124 | 0.0089 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0048 | 0.1389 | 0.1389 |
Plasmodium falciparum | glutathione reductase | 0.0065 | 0.2452 | 0.2425 |
Schistosoma mansoni | hypothetical protein | 0.0174 | 0.9115 | 0.9059 |
Onchocerca volvulus | 0.0082 | 0.3462 | 1 | |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0035 | 0.0594 | 0.0594 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0065 | 0.2452 | 0.1725 |
Toxoplasma gondii | thioredoxin reductase | 0.0188 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.1587 | 0.1587 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0188 | 1 | 1 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0065 | 0.2452 | 0.2452 |
Plasmodium vivax | glutathione reductase, putative | 0.0188 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0038 | 0.0806 | 0.0774 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0038 | 0.0806 | 0.0774 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0065 | 0.2452 | 0.1725 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0188 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0878 | 0.0846 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0065 | 0.2452 | 0.1975 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0027 | 0.0124 | 0.0089 |
Trypanosoma brucei | hexokinase, putative | 0.0082 | 0.3462 | 0.3439 |
Leishmania major | hexokinase, putative | 0.0082 | 0.3462 | 0.3439 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 50.7 uM | Inhibition of Mycobacterium tuberculosis recombinant antigen 85C mycolyltransferase | ChEMBL. | 17010479 |
IC50 (binding) | = 50.7 uM | Inhibition of Mycobacterium tuberculosis recombinant antigen 85C mycolyltransferase | ChEMBL. | 17010479 |
IC50 (binding) | = 50.74 uM | In vitro concentration required to inhibit antigen 85C mycolyltransferase activity in Mycobaterium tuberculosis | ChEMBL. | 15177473 |
IC50 (binding) | = 50.74 uM | In vitro concentration required to inhibit antigen 85C mycolyltransferase activity in Mycobaterium tuberculosis | ChEMBL. | 15177473 |
MIC (functional) | = 406.1 ug ml-1 | Growth inhibition of Mycobacterium avium 2447 | ChEMBL. | 17010479 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.